Challenge: Diseases of the eye, sometimes leading to blindness represent an enormous burden in terms of human suffering and economic cost. New gene therapies where promoters act as switches to modulate gene expression could offer cures, but such expression is difficult to target to the appropriate diseased cells. Due to their size, complexity and regulation,…
Congrats Sandrine Campeau. CQDM is proud to announce the internal promotion of Sandrine Campeau as Administration Director. In her new role, Sandrine will assume responsibilities for the entire CQDM administration, such as HR, IT, governance, operational management and others. According to Alysia Melnychuk, CPA, her immediate superior: “Sandrine is the backbone that unites and supports…
Subscribe to our newsletters. Our September 18 newsletter was released this morning. Did you receive it? You can register here. In this edition: Connect-Pharma – connect with the world’s largest pharmaceutical companies during our pitch day, several job offers available at CQDM, appointment to our team, 4,000 LinkedIn subscribers and various projects financed by CQDM.…
CQDM. We do it. We are very proud to announce that we have reached a “new peak”: 4,000 subscribers to our LinkedIn page! One more “level” reached in our quest to provide you with news and information relating to innovations in biopharmaceutical research, life sciences, pharmaceuticals and health. We also share CQDM and ecosystem news,…
CQDM. We grow.CQDM is proud to announce the internal promotion of Sandra Constantin as Program Manager and EDI Lead! In her new role, Sandra will ensure the efficient and rigorous management of CQDM funding programs (excluding the FACS program) as well as all projects in the portfolio. She will also continue to play her role…
CQDM. We grow.CQDM is proud to announce the addition of a new member to its team! Welcome to Dorothy E. Josué, CPA who joins as Chief Accountant. Prior to her arrival, Dorothy was an accountant with Domtar in corporate accounting. She also began her career as an assistant accountant with a Quebec family business.After obtaining…
CQDM. We grow.CQDM is proud to announce the addition of a new member to its team! Welcome to Aren Bezdjian, PhD who joins as Manager, Special Projects. Before joining CQDM, Aren worked as a senior clinical research manager at the Montreal Neurological Institute and for Oticon Medical. Together with his teams, he developed and led…
ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and…
Montreal, August 10th, 2023 – CQDM is proud to present a new series of events: Connect-Pharma. CQDM launches Connect-Pharma, with a first event for fall 2023: Pitch Day. CQDM is pleased to launch a call for ideas for our new Connect-Pharma: Pitch Day event. We are searching for world-class research to develop novel and efficient approaches for…
ABOUT CQDM Since its inception, CQDM has raised more than $275 million to fund the development of 150 + drugs addressing major health challenges, including cancer, neurodegenerative and metabolic diseases. CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative tools and technologies that accelerate the development of safe and…